telmisartan has been researched along with Hypertension, Essential in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, S; Anand, J; Bachani, D; Doshi, M; Gaikwad, VB; Halder, SK; Kinholkar, B; Kumar, DA; Kumbhar, A; Mathur, R; Mehta, S; Sarkar, G; Sharma, A | 1 |
| Ahn, JC; Cho, EJ; Han, SH; Kang, SM; Kim, KH; Kim, KI; Kim, SY; Kim, W; Kim, YJ; Park, CG; Park, SJ; Park, SM; Shin, J; Shin, JH; Sohn, IS; Sung, JH; Sung, KC | 1 |
| Chen, S; Dong, P; Liu, H; Zhao, D | 1 |
| Liang, H; Tang, T; Xie, M | 1 |
| Ahn, Y; Cha, KS; Chang, K; Cho, EJ; Choi, DJ; Choi, SY; Doh, JH; Hong, SJ; Hong, SP; Hwang, JY; Hyon, MS; Ihm, SH; Kang, WC; Kim, HS; Kim, MH; Kim, SH; Kim, WS; Kim, YH; Kwon, K; Lee, JH; Lee, N; Lim, SW; Rhee, MY; Shin, J; Son, JW; Yoo, BS | 1 |
| Chen, XP; Li, HL; Luo, J; Shi, LH; Zhang, ZL; Zhao, JF; Zhu, MM | 1 |
| Ahn, JC; Ahn, JH; Ahn, YK; Cha, DH; Chae, IH; Cho, DK; Cho, SK; Choi, YJ; Hong, SJ; Hong, TJ; Hyon, MS; Jang, JY; Jeon, DW; Jeong, JO; Kim, BS; Kim, HS; Kim, SH; Nam, CW; Oh, YS; Park, SH; Rha, SW; Song, JM; Sung, KC; Won, KH; Yang, TH; Yoo, BS; Yoo, KD; Yoon, YW | 1 |
| Dong, P; Liu, H; Zhao, D | 1 |
| Chai, Q; Chen, Y; Cui, Y; Dong, Y; Duan, D; Gong, G; Hu, W; Ji, T; Liu, Z; Sheng, L; Sun, S; Wang, J; Zhang, H; Zhao, Y; Zhou, T | 1 |
| Chokalingam, K; Dhawan, S; Hiremath, JS; Mathan, G; Reddy, PNC; Sharma, A; Toppo, A | 1 |
| Chen, BX; Du, FH; Gong, HT; Guo, CX; Li, Q; Ma, XL; Xu, XY | 1 |
| Dika, Z; Fodor, L; Ivković, V; Jelaković, B; Laganović, M; Perkov, D; Premužić, V; Vrkić, TZ; Zivko, M | 1 |
| Chen, XP; Li, HL; Wen, ZP; Yang, GP; Zhang, W; Zhang, ZL | 1 |
| Higaki, J; Ikeda, H; Komuro, I; Kuroki, D; Nishimura, S; Ogihara, T; Shiki, K; Taniguchi, A; Ugai, H | 1 |
3 review(s) available for telmisartan and Hypertension, Essential
| Article | Year |
|---|---|
Antihypertensive effect of telmisartan versus perindopril in hypertensive patients.
Topics: Antihypertensive Agents; Benzimidazoles; Essential Hypertension; Humans; Hypertension; Perindopril; Telmisartan | 2023 |
Efficacy of single-pill combination in uncontrolled essential hypertension: A systematic review and network meta-analysis.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Essential Hypertension; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Losartan; Network Meta-Analysis; Telmisartan; Tetrazoles; Valine; Valsartan | 2023 |
A Meta-analysis of antihypertensive effect of telmisartan versus candesartan in patients with essential hypertension.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Essential Hypertension; Humans; Randomized Controlled Trials as Topic; Telmisartan; Tetrazoles | 2019 |
8 trial(s) available for telmisartan and Hypertension, Essential
| Article | Year |
|---|---|
Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Coronary Artery Disease; Drug Therapy, Combination; Essential Hypertension; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Metoprolol; Telmisartan; Tetrazoles | 2022 |
Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trial.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Essential Hypertension; Humans; Hypertension; Telmisartan; Treatment Outcome | 2022 |
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trial.
Topics: Aged; Amlodipine; Chlorthalidone; Essential Hypertension; Female; Humans; Hypertension; Leukemia, Myeloid, Acute; Male; Middle Aged; Telmisartan | 2023 |
Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI St
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dizziness; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Essential Hypertension; Female; Headache; Humans; Hydrochlorothiazide; Male; Middle Aged; Telmisartan; Treatment Outcome; Young Adult | 2018 |
Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension: a randomized, double-blind and placebo-controlled clinical trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Cognitive Dysfunction; Disease Progression; Double-Blind Method; Essential Hypertension; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukoencephalopathies; Male; Middle Aged; Rosuvastatin Calcium; Telmisartan | 2019 |
A Randomized, Double-blinded, Controlled, Multicentre Phase III Study to Evaluate the Efficacy and Safety of Telmisartan /Amlodipine/Hydrochlorothiazide Compared to Telmisartan/Hydrochlorothiazide in Patients with Essential Hypertension.
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Drug Therapy, Combination; Essential Hypertension; Humans; Hydrochlorothiazide; Telmisartan | 2018 |
Polymorphisms of the angiotensin II type 1 receptor gene affect antihypertensive response to angiotensin receptor blockers in hypertensive Chinese.
Topics: Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Asian People; Benzimidazoles; Benzoates; Blood Pressure; Drug Administration Schedule; Essential Hypertension; Female; Genotype; Humans; Hypertension; Male; Middle Aged; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Single-Blind Method; Telmisartan; Young Adult | 2013 |
The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Hypertension; Japan; Male; Middle Aged; Telmisartan; Treatment Outcome | 2017 |
3 other study(ies) available for telmisartan and Hypertension, Essential
| Article | Year |
|---|---|
Influence of PRKCH gene polymorphism on antihypertensive response to amlodipine and telmisartan.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Arterial Pressure; Asian People; Benzimidazoles; Benzoates; Essential Hypertension; Female; Heart Rate; Heterozygote; Homozygote; Humans; Male; Middle Aged; Polymorphism, Genetic; Protein Kinase C; Telmisartan | 2017 |
Arterial stiffness in atherosclerotic renovascular hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aorta; Atherosclerosis; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Essential Hypertension; Female; Humans; Hypertension; Hypertension, Renovascular; Longitudinal Studies; Male; Middle Aged; Pulse Wave Analysis; Renin-Angiotensin System; Risk Factors; Stents; Telmisartan; Vascular Stiffness | 2014 |
Influence of G-protein β-Polypeptide 3 C825T Polymorphism on Antihypertensive Response to Telmisartan and Amlodipine in Chinese Patients.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Essential Hypertension; Female; Genotype; Heterotrimeric GTP-Binding Proteins; Humans; Hypertension; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Telmisartan | 2016 |